| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 6,263 | 6,029 | | Cost of Revenue | 4,360 | 3,840 | | | Gross Profit | 1,903 | 2,189 | | | Operating Expenses | | Research Development | 4,913 | 6,022 | | Selling General and Administrative | 9,220 | 9,458 | | Non Recurring |
-
|
-
| | Others | 1,410 | 1,332 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (13,640) | (14,623) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (503) | 3,091 | | Earnings Before Interest And Taxes | (14,143) | (12,553) | | Interest Expense | 862 |
-
| | Income Before Tax | (15,005) | (12,553) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (15,005) | (12,553) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (15,005) | (12,553) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($15,005) | ($12,553) |
|
0.29% Nasdaq 
Income Statement
